Clinical application of in vivo proton (1H) MR spectroscopy in musculoskeletal tumors

Spectroscopy

Volumn 19, Issue 4, 2005, Pages 181-190

  Wang, Chien Kuo ^a,b   Hsieh, Tsyh Jyi ^a   Jaw, Twei Shiun ^a,b   Lin, Jau Nan ^b   Liu, Gin Chung ^a,b   Li, Chun Wei ^c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

In vivo proton MRS; MRI; Musculoskeletal tumors

Indexed keywords

DIAGNOSIS; DISEASE CONTROL; MUSCULOSKELETAL SYSTEM; PATIENT MONITORING; SPECTROSCOPIC ANALYSIS; TUMORS;

CHEMICAL CONTENT; CLINICAL APPLICATIONS; IN VIVO PROTON MRS; MUSCULOSKELETAL TUMORS;

MAGNETIC RESONANCE IMAGING;

ARTICLE; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; HUMAN; MEDICAL LITERATURE; MUSCULOSKELETAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 27744581882     PISSN: 07124813     EISSN: None     Source Type: Journal    
DOI: 10.1155/2005/283645     Document Type: Article

References (34)

1. P.F. Daly and J.S. Cohen, Magnetic resonance spectroscopy of tumors and potential in vivo clinical applications: a review, Cancer Res. 49(4) (1989), 770-779.
2. I.C. Smith and D.E. Blandford, Diagnosis of cancer in humans by 1H NMR of tissue biopsies, Biochemistry & Cell Biology 76(2-3) (1998), 472-476.
3. B.L. Miller, A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline, NMR Biomed. 4(2) (1991), 47-52.
4. W. Negendank, Studies of human tumors by MRS: a review, NMR in Biomedicine 5(5) (1992), 303-324.
5. J. Ruiz-Cabello and J.S. Cohen, Phospholipid metabolites as indicators of cancer cell function, NMR Biomed. 5(5) (1992), 226-233.
6. W.B. Mackinnon, P.A. Barry, P.L. Malycha, D.J. Gillett, P. Russell, C.L. Lean, S.T. Doran, B.H. Barraclough, M. Bilous and C.E. Mountford, Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy, Radiology 204(3) (1997), 661-666.
7. K. Millis, P. Weybright, N. Campbell, J.A. Fletcher, C.D. Fletcher, D.G. Cory and S. Singer, Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy, Magnetic Resonance in Medicine 41(2) (1999), 257-267.
8. S.K. Mukherji, S. Schiro, M. Castillo, L. Kwock, R. Soper, W. Blackstock, W. Shockley and M. Weissler, Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. Am. J. Neuroradiol. 17(8) (1996), 1485-1490.
9. N. Oya, J. Aoki, T. Shinozaki, H. Watanabe, K. Takagishi and K. Endo, Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor, Radiation Medicine 18(3) (2000), 193-198.
10. K.A. Kvistad, I.J. Bakken, I.S. Gribbestad, B. Ehrnholm, S. Lundgren, H.E. Fjosne and O. Haraldseth, Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy, J. Magn. Reson. Imaging 10(2) (1999), 159-164.
11. D.K.W. Yeung, H.S. Cheung and G.M.K. Tse, Human breast lesions: Characterization with contrast-enhanced in vivo proton MR spectroscopy: initial results, Radiology 220(1) (2001), 40-46.
12. 3) spatial resolution, Radiology 198(3) (1996), 795-805.
13. J.R. Allen, R.W. Prost, D.W. Griffith, S.J. Erickson and B.A. Erickson, In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma, American Journal of Clinical Oncology 24(5) (2001), 522-529.
14. C.K. Wang, C.W. Li, T.J. Hsieh, S.H. Chien, G.C. Liu and K.B. Tsai, Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results, Radiology 232(2) (2004), 599-605.
15. J. Frahm, H. Bruhn, M.L. Gyngell, K.D. Merboldt, W Hanicke and R. Sauter, Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo, Magn. Reson. Med. 9(1) (1989), 79-93.
16. P.A. Bottomley, Spatial localization in NMR spectroscopy in vivo, Ann. NY Acad. Sci. 508 (1987), 333-348.
17. T.R. Brown, B.M. Kincaid and K. Ugurbil, NMR chemical shift imaging in three dimensions, Proc. Natl. Acad. Sci. USA 79(11) (1982), 3523-3526.
18. A.A. Maudsley, S.K. Hilal, W.H. Perman and H.E. Simon, Spatially resolved high resolution spectroscopy by "four-dimensional" NMR, Journal of Magnetic Resonance (1969) 51(1) (1983), 147.
19. I.M. Brereton, J. Field, L.N. Moxon, M.G. Irving and D.M. Doddrell, Water suppression with B0 field gradient homospoil pulses in high-resolution NMR spectroscopy, Magn. Reson. Med. 9(1) (1989), 118-125.
20. M. Mescher, H. Merkle, J. Kirsch, M. Garwood and R. Gruetter, Simultaneous in vivo spectral editing and water suppression, NMR Biomed. 11(6) (1998), 266-272.
21. D.L. Rabenstein, S. Fan and T.T. Nakashima, Attenuation of the water resonance in fourier transform 1H NMR spectra of aqueous solutions by spin-spin relaxation, Journal of Magnetic Resonance (1969) 64(3) (1985), 541.
22. R.G. Males, D.B. Vigneron, J. Star-Lack, S.C. Falbo, S.J. Nelson, H. Hricak and J. Kurhanewicz, Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging, Magn. Reson. Med. 43(1) (2000), 17-22.
23. H.J. van der Woude, K.L. Verstraete, P.C. Hogendoorn, A.H. Taminiau, J. Hermans and J.L. Bloem, Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization?, Radiology 208(3) (1998), 821-828.
24. P.S. Tofts and S. Wray, A critical assessment of methods of measuring metabolite concentrations by NMR spectroscopy, NMR Biomed. 1(1) (1988), 1-10.
25. E.R. Danielsen and O. Henriksen, Absolute quantitative proton NMR spectroscopy based on the amplitude of the local water suppression pulse. Quantification of brain water and metabolites, NMR Biomed. 7(7) (1994), 311-318.
26. E.R. Danielsen, T. Michaelis and B.D. Ross, Three methods of calibration in quantitative proton MR spectroscopy, J. Magn. Reson. B 106(3) (1995), 287-291.
27. R. Kreis and B.D. Ross, Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy, Radiology 184(1) (1992), 123-130.
28. J. Frahm, H. Bruhn, M.L. Gyngell, K.D. Merboldt, W. Hanicke and R. Sauter, Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites, Magn. Reson. Med. 11(1) (1989), 47-63.
29. B.J. Soher, R.E. Hurd, N. Sailasuta and P.B. Barker, Quantitation of automated single-voxel proton MRS using cerebral water as an internal reference, Magn. Reson. Med. 36(3) (1996), 335-339.
30. S.D. Rand, R. Prost, V. Haughton, L. Mark, J. Strainer, J. Johansen, T.A. Kim, V.K. Chetty, W. Mueller, G. Meyer and H. Krouwer, Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions, American Journal of Neuroradiology 18(9) (1997), 1695-1704.
31. H.G. Krouwer, T.A. Kim, S.D. Rand, R.W. Prost, V.M. Haughton, K.C. Ho, S.S. Jaradeh, G.A. Meyer, K.A. Blindauer, J.F. Cusick, G.L. Morris and P.R. Walsh, Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm, American Journal of Neuroradiology 19(9) (1998), 1695-1703.
32. S.R. Maheshwari, S.K. Mukherji, B. Neelon, S. Schiro, G.M. Fatterpekar, J.A. Stone and M. Castillo, The choline/creatine ratio in five benign neoplasms: comparison with squamous cell carcinoma by use of in vitro MR spectroscopy, American Journal of Neuroradiology 21(10) (2000), 1930-1935.
33. A. Bitsch, H. Bruhn, V. Vougioukas, A. Stringaris, H. Lassmann, J. Frahm and W. Bruck, Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy, American Journal of Neuroradiology 20(9) (1999), 1619-1627.
34. A.J. Schwarz, N.R. Maisey, D.J. Collins, D. Cunningham, R. Huddart and M.O. Leach, Early in vivo detection of metabolic response: a pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours, Br. J. Radiol. 75(900) (2002), 959-966.